Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦Worldwide Shipping✦For research purposes only.✦We guarantee quality and assurance.✦
MedTruva
BODYMAP™ About Sign in
Medtruva TESA+IPA 10mg/5mg research peptide vial

TESA+IPA (Tesamorelin + Ipamorelin)

$140.00

Tesamorelin 10 mg + Ipamorelin 5 mg research blend for controlled laboratory studies of combined GHRH-receptor and ghrelin-receptor (GHS-R1a) signaling. Research use only.

Blend composition

2 actives
15 mg

total peptide content 10 / 5

Tesamorelin10 mg66.7%
Ipamorelin5 mg33.3%
Percentages based on stated nominal mass.

US ordering opens soon. Researchers in Dubai can order now by switching to the UAE store.

98.99%+ PurityResearch GradeCOA VerifiedThird-Party Tested
View the certificate of analysis for this compound →

Not available to order yet — coming soon.

American based – premium qualityTrusted brand – customers choice100% tested – premium qualityCOA certified – lab tested, always trustedBest pricing – always competitive

The Purity Guarantee

Verified ≥99% by HPLC & mass spectrometry, third-party tested, with a lot-matched Certificate of Analysis on every vial.

  • Certificate of Analysis available for every lot
  • ≥99% purity, HPLC & mass-spec verified
  • Secure checkout · Free shipping on orders $300+
SKU: MT-TESA-IPA Category:

Description

TESA+IPA is a two-compound research blend combining Tesamorelin (10 mg) and Ipamorelin (5 mg) in a single lyophilized vial. Tesamorelin is a stabilized synthetic analog of full-length growth hormone-releasing hormone, GHRH(1–44), carrying an N-terminal trans-3-hexenoyl modification that protects it from rapid enzymatic cleavage. Ipamorelin is a selective pentapeptide agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Because the two compounds act on complementary receptors within the same somatotroph signaling axis, the pairing is widely used as a reference system for studying combined GHRH-R and GHS-R1a activation. It is supplied here for controlled analytical and laboratory investigation of dual-pathway growth hormone secretagogue signaling.

Research focus

  • Combined GHRH-receptor and GHS-R1a (ghrelin receptor) activation
  • Additive and synergistic effects on pulsatile growth hormone release models
  • Receptor selectivity and comparison with single-agent Sermorelin or Ipamorelin

This Medtruva catalog product is a laboratory research material, not a clinical product. Store and prepare it only according to an appropriate research protocol, and review all available documentation before use.

For laboratory research use only. Not for human consumption, diagnosis, treatment, or veterinary use.

Certificate of Analysis

Every Medtruva lot ships with an independent, third-party certificate of analysis covering identity and purity. The certificate for each lot is published here and searchable by lot number.

Sample · Lab verification in progress
CompoundTESA+IPA (Tesamorelin + Ipamorelin) · MT-TESA-IPA
Lot numberAssigned at first production run
Analytical methodsRP-HPLC (purity) · LC-MS (identity)
PurityPending lab verification
Testing laboratoryIndependent third-party laboratory
Report datePending

Sample certificate. Laboratory testing for the launch lots is in progress. The document below is a sample showing the format every Medtruva certificate follows; it will be replaced by the signed lab report for this lot before ordering opens.

View sample certificate (PDF) Look up a lot number →

For laboratory research only. Certificates describe the analytical results of a specific lot and are not a statement of suitability for any use.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products